Description
Founded in 2013, Brace Pharma Capital is a corporate venture capital firm that is based in Atlanta, Georgia. The firm prefers to invest in seed-stage, early-stage, and later-stage companies. The firm prefers to invest in the healthcare, life sciences, and oncology sectors.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Antiva Biosciences | 02-Nov-2021 | Later Stage VC | 0000 | Drug Discovery | Generating Revenue | 0000000 0000000 |
000000000 00000000 | 14-Jul-2021 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | |
00000000 000000000 | 11-Feb-2021 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 1 | 0000 00000 |
0000000 | 25-Aug-2020 | 00000 00000 | 000.00 | Drug Discovery | Clinical Trials - Phase 2 | |
000 | 12-Aug-2020 | 00000 00000 | 000.00 | Drug Discovery | Clinical Trials - Phase 2 | |
0000000 0000000000 | 21-May-2020 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | |
00000000 000000000 | 18-Dec-2019 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 1 | 0000 00000 |
0000000 0000000000 | 13-Nov-2019 | 00000 00000 | 00000 | Drug Discovery | Generating Revenue/Not Profitable | 0000 00000 |
Precision BioSciences | 01-Mar-2019 | Later Stage VC | 00000 | Biotechnology | Generating Revenue/Not Profitable | |
Turnstone Biologics | 04-Jan-2019 | Later Stage VC | 0000 | Drug Discovery | Generating Revenue |
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Avidity Biosciences | 12-Jun-2020 | IPO | 00000 |
000000000 00000000 | 28-Mar-2019 | 000 | 00000 |
000000000 00000000 | 01-Nov-2018 | 000 00 00000000 | |
0000000 | 21-Jun-2018 | 000 | 00000 |
000000 00000000000 | 29-Mar-2018 | 000 | 000.00 |
000000000 | 28-Apr-2017 | 000 | 000.00 |
Cocrystal Pharma | 02-Jan-2014 | Reverse Merger | |
Viridian Therapeutics | Secondary Transaction - Open Market |
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Vinzenz Ploerer | President & Chief Executive Officer | 0 | 0 | 0 | Rockville, MD |
Jorge Costa Ph.D | Co-Founding Director & Member of Scientific Advisory Board | Cambridge, MA | |||
Todd Brady | Director of Finance & Investments | 0 | 0 | 0 | Rockville, MD |
Racheal Smith | Executive Assistant & Office Manager | Atlanta, GA | |||
Daniel Salazar Ph.D | Vice President of Clinical & Regulatory | 0 | Rockville, MD |
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Alexandria Venture Investments | 3 | 0 |
![]() |
![]() |
|
Cormorant Asset Management | 0 | 0 | 0 |
![]() |
![]() |
Perceptive Advisors | 0 | 0 | 0 |
![]() |
![]() |
Atlas Venture | 0 | 0 | 0 |
![]() |
![]() |
Franklin Templeton | 0 | 0 |
![]() |
![]() |